Safe S.A. specializes in the design, manufacture and marketing of medical devices for spine surgery. The company offers implants and instruments in the range of SteriSpine (the first spinal arthrodesis system that is for single use and is sterile and totally traceable). The group's activity is organized around 2 areas: - direct and indirect sales of medical devices (Safe Orthopaedics): business carried out in France, Germany, the United Kingdom, the United States and South America; - subcontracted manufacturing services for orthopedic medical devices (Safe Medical).

Employees

Sector

Medical Equipment, Supplies & Distribution

More about the company

Quotes

Date	Price	Change
26-08-17	€0.6400	0.00%
26-08-14	€0.6400	0.00%
26-08-13	€0.6400	0.00%
26-08-12	€0.6400	0.00%
26-08-11	€0.6400	0.00%

Real-time Euronext Paris

More quotes

Income Statement and Estimates

More financial data

Real-time Euronext Paris 11:55:00 2026-08-17 EDT			5-day change	1st Jan Change
0.6400 ^EUR	0.00%		0.00%	-63.43%

06-30	Safe Group sharply improves its full-year results
06-28	Safe Orthopaedics SA Reports Earnings Results for the Full Year Ended December 31, 2025	CI

Market Cap	128K 148K 120K 109K 205K 14.12M 208K 1.4M 550K 7.08M 555K 543K 23.54M	P/E 2024 *	-	P/E 2025	-0.07x
Enterprise Value	13.24M 15.34M 12.42M 11.31M 21.27M 1.47B 21.57M 146M 57.06M 735M 57.58M 56.33M 2.44B	EV / Sales 2024	2.39x	EV / Sales 2025	2.47x
Free-Float	87.27%	Yield 2024 *	-	Yield 2025	-

06-30	Safe Group sharply improves its full-year results
06-28	Safe Orthopaedics SA Reports Earnings Results for the Full Year Ended December 31, 2025	CI
05-28	Safe And ABL Alpstein Sign Exclusive Distribution Agreement For SteriSpine Range In Peru	CI
05-28	Safe Group enters Peru with exclusive distribution agreement
03-16	Changes to the SAFE Board of Directors
12-17	Safe Orthopaedics Signs Exclusive Distribution Agreement for Spanish Market	MT
12-17	Safe Group Signs Strategic Distribution Agreement in Spain with Vortrom Biologics	CI
11-30	Safe Orthopaedics SA Reports Earnings Results for the Full Year Ended December 31, 2024	CI
25-07-28	Alert wrongly tagged to Safe SA withdrawn	RE
24-12-27	Safe Orthopaedics SA Reports Earnings Results for the Half Year Ended June 30, 2024	CI
24-09-09	The market burns its idols
24-02-05	Safe: wins its appeal against Neo Medical
23-12-28	Safe: audit initiated for a turnaround plan

12-22	SAFE, SPONSOR OF THE 12TH MAMMI INTERNATIONAL CONFERENCE IN ITALY	GL
12-17	SAFE SIGNS A STRATEGIC DISTRIBUTION AGREEMENT IN SPAIN WITH VORTROM BIOLOGICS	GL
12-17	SAFE SIGNS A STRATEGIC DISTRIBUTION AGREEMENT IN SPAIN WITH VORTROM BIOLOGICS	AQ
24-09-09	New bond financing agreement in a minimum amount of €3 million in anticipation of validation of the continuation plan	GL
23-11-24	Safe group announces the convocation of the Annual General Meeting of Shareholders to be held on December 15th 2023 and provides an update on the situation	AQ

Safe S.A. Stock

Stocks

ALSAF

FR001400ZU25

Medical Equipment, Supplies & Distribution

Valuation: Safe S.A.

Chart: Safe S.A.

Latest news : Safe S.A.

Press Releases: Safe S.A.

News in other languages: Safe S.A.

Quotes and Performance

Course Extremes

Managers and Directors: Safe S.A.

Latest insider transactions

Medical Devices & Implants

Financials

Company Profile

Quotes

Income Statement and Estimates

06-30	Safe Group améliore nettement ses résultats annuels
05-28	Safe Group s'implante au Pérou avec un accord de distribution exclusif
04-28	Safe S A : Report de la publication des résultats annuels 2025 de SAFE Group
03-31	SAFE - Forte dynamique de développement au Venezuela
03-16	Evolutions au sein du Conseil d'Administration de SAFE

1 week	0.64	0.64
1 month	0.64	0.64
Current year	0.54	1.81
1 year	0.54	2.6
3 years	0.54	179,717.97
5 years	0.54	6,204,899,937.95
10 years	0.54	10,000,000,000

Manager	Title	Age	Since
Nicolas Papillon CEO	Chief Executive Officer	46	-
Thomas Droulout CTO	Chief Tech/Sci/R&D Officer	50	2010-02-14
François-Henri Reynaud DFI	Director of Finance/CFO	-	2017-11-08

Director	Title	Age	Since
Thomas Droulout BRD	Director/Board Member	50	-
François-Henri Reynaud BRD	Director/Board Member	-	2019-11-25
Ismaël Nujurally BRD	Director/Board Member	69	2019-11-25

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
SAFE S.A.	0.00%	0.00%	-73.33%	-100.00%	148K
STRYKER CORPORATION	-2.22%	-4.09%	-13.15%	+19.34%	127B
SMITH & NEPHEW PLC	+1.84%	-0.36%	-18.10%	+3.23%	12.41B
GLAUKOS CORPORATION	+0.59%	+2.32%	+106.57%	+157.41%	10.94B
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.	-1.32%	-5.77%	-45.30%	-68.20%	4.45B
DOUBLE MEDICAL TECHNOLOGY INC.	-2.01%	-0.57%	-25.77%	+42.51%	2.67B
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.	-0.05%	-2.43%	-21.35%	-13.61%	1.66B
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD.	-1.56%	-2.27%	-34.51%	-36.28%	1.64B
INSPIRE MEDICAL SYSTEMS, INC.	+0.21%	-4.19%	-34.81%	-72.87%	1.65B
Average	-0.50%	-1.79%	-17.75%	-7.61%	18.07B
Weighted average by Cap.	-1.64%	-3.37%	-7.08%	+23.55%

	2024	2025
Net sales	5.04M 5.84M 4.73M 4.31M 8.1M 558M 8.21M 55.44M 21.72M 280M 21.92M 21.45M 930M	5.36M 6.21M 5.03M 4.58M 8.62M 594M 8.74M 58.99M 23.12M 298M 23.33M 22.82M 990M
Net income	-1.93B -2.23B -1.81B -1.65B -3.1B -214B -3.14B -21.22B -8.31B -107B -8.39B -8.21B -356B	-4.67M -5.41M -4.38M -3.99M -7.51M -518M -7.61M -51.4M -20.14M -259M -20.33M -19.89M -863M
Net Debt	11.47M 13.29M 10.76M 9.8M 18.43M 1.27B 18.69M 126M 49.44M 636M 49.89M 48.81M 2.12B	13.11M 15.19M 12.3M 11.2M 21.07M 1.45B 21.36M 144M 56.51M 728M 57.02M 55.79M 2.42B

3 months	+4.92%
6 months	-32.28%
Current year	-63.43%